Template:SUIT-015: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
|- | |- | ||
| 1OctM | | 1OctM | ||
| [[OctM]]<sub>''L''</sub> | | [[OctM]]<sub>''[[L]]''</sub> | ||
| [[Fatty acid oxidation pathway control state|F(N)]] | | [[Fatty acid oxidation pathway control state|F(N)]] | ||
| CETF | | CETF | ||
| | | 1OctM | ||
{{Template:SUIT F}} {{Template:SUIT L(n)}} | *{{Template:SUIT F}} | ||
*{{Template:SUIT L(n)}} | |||
|- | |- | ||
| 2D | | 2D | ||
| [[OctM]]<sub>''P''</sub> | | [[OctM]]<sub>''[[OXPHOS|P]]''</sub> | ||
| [[Fatty acid oxidation pathway control state|F(N)]] | | [[Fatty acid oxidation pathway control state|F(N)]] | ||
| CETF | | CETF | ||
| 1OctM;2D | | 1OctM;2D | ||
{{Template:SUIT F}} {{Template:SUIT OXPHOS}} | *{{Template:SUIT F}} | ||
*{{Template:SUIT OXPHOS}} | |||
|- | |- | ||
| 2c | | 2c | ||
| [[OctM]]c<sub>''P''</sub> | | [[OctM]]c<sub>''[[OXPHOS|P]]''</sub> | ||
| [[Fatty acid oxidation pathway control state|F(N)]] | | [[Fatty acid oxidation pathway control state|F(N)]] | ||
| CETF | | CETF | ||
| 1OctM;2D;2c | | 1OctM;2D;2c | ||
{{Template:SUIT F}} {{Template:SUIT OXPHOS}} {{Template:SUIT c}} | *{{Template:SUIT F}} | ||
*{{Template:SUIT OXPHOS}} | |||
*{{Template:SUIT c}} | |||
|- | |- | ||
| 3G | | 3G | ||
| [[OctGM]]<sub>''P''</sub> | | [[OctGM]]<sub>''[[OXPHOS|P]]''</sub> | ||
| [[FN]] | | [[FN]] | ||
| CETF&I | | CETF&I | ||
| 1OctM;2D;3G | | 1OctM;2D;2c;3G | ||
{{Template:SUIT F}} & {{Template:SUIT N}} {{Template:SUIT FN}} {{Template:SUIT OXPHOS}} | *{{Template:SUIT F}} & {{Template:SUIT N}} | ||
*{{Template:SUIT FN}} | |||
*{{Template:SUIT OXPHOS}} | |||
|- | |- | ||
| 4P | | 4P | ||
| [[OctPGM]]<sub>''P''</sub> | | [[OctPGM]]<sub>''[[OXPHOS|P]]''</sub> | ||
| [[FN]] | | [[FN]] | ||
| CETF&I | | CETF&I | ||
| 1OctM;2D;3G;4P | | 1OctM;2D;2c;3G;4P | ||
{{Template:SUIT F}} & {{Template:SUIT N}} {{Template:SUIT FN}} {{Template:SUIT OXPHOS}} | *{{Template:SUIT F}} & {{Template:SUIT N}} | ||
*{{Template:SUIT FN}} | |||
*{{Template:SUIT OXPHOS}} | |||
|- | |- | ||
| 5S | | 5S | ||
| [[OctPGMS]]<sub>''P''</sub> | | [[OctPGMS]]<sub>''[[OXPHOS|P]]''</sub> | ||
| [[FNS]] | | [[FNS]] | ||
| CETF&CI&II | | CETF&CI&II | ||
| 1OctM;2D;3G;4P;5S | | 1OctM;2D;2c;3G;4P;5S | ||
{{Template:SUIT F}} & {{Template:SUIT N}} {{Template:SUIT S}} {{Template:SUIT | *{{Template:SUIT F}} & {{Template:SUIT N}} | ||
*{{Template:SUIT S}} | |||
*{{Template:SUIT FNS}} | |||
*{{Template:SUIT OXPHOS}} | |||
|- | |- | ||
| 6U | | 6U | ||
| [[OctPGMS]]<sub>''E''</sub> | | [[OctPGMS]]<sub>''[[E]]''</sub> | ||
| [[FNS]] | | [[FNS]] | ||
| CETF&CI&II | | CETF&CI&II | ||
| 1OctM;2D;3G;4P;5S;6U | | 1OctM;2D;2c;3G;4P;5S;6U | ||
{{Template:SUIT F}} & {{Template:SUIT N}} {{Template:SUIT S}} {{Template:SUIT | *{{Template:SUIT F}} & {{Template:SUIT N}} | ||
*{{Template:SUIT S}} ย | |||
*{{Template:SUIT FNS}} ย | |||
*{{Template:SUIT U*}} ย | |||
*{{Template:SUIT ET}} | |||
|- | |- | ||
| 7Rot | | 7Rot | ||
| [[S]]<sub>''E''</sub> | | [[S]]<sub>''[[E]]''</sub> | ||
| [[S]] | | [[S]] | ||
| CII | | CII | ||
| 1OctM;2D;3G;4P;5S;6U;7Rot | | 1OctM;2D;2c;3G;4P;5S;6U;7Rot | ||
{{Template:SUIT Rot}} {{Template:SUIT ET}} | *{{Template:SUIT Rot}} | ||
*{{Template:SUIT ET}} | |||
|- | |- | ||
Line 83: | Line 99: | ||
| ย | | ย | ||
|ย ย | |ย ย | ||
| 1OctM;2D;3G;4P;5S;6U;7Rot | | 1OctM;2D;2c;3G;4P;5S;6U;7Rot | ||
{{Template:SUIT Ama}} ย | *{{Template:SUIT Ama}} ย | ||
|} | |} |
Revision as of 17:00, 28 January 2019
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
1OctM | OctML | F(N) | CETF | 1OctM
|
2D | OctMP | F(N) | CETF | 1OctM;2D
|
2c | OctMcP | F(N) | CETF | 1OctM;2D;2c
|
3G | OctGMP | FN | CETF&I | 1OctM;2D;2c;3G
|
4P | OctPGMP | FN | CETF&I | 1OctM;2D;2c;3G;4P
|
5S | OctPGMSP | FNS | CETF&CI&II | 1OctM;2D;2c;3G;4P;5S
|
6U | OctPGMSE | FNS | CETF&CI&II | 1OctM;2D;2c;3G;4P;5S;6U
|
7Rot | SE | S | CII | 1OctM;2D;2c;3G;4P;5S;6U;7Rot
|
8Ama | ROX | 1OctM;2D;2c;3G;4P;5S;6U;7Rot
|
Step | Respiratory state | Pathway control | ET-Complex | Comment |
---|---|---|---|---|
## AsTm | AsTmE | CIV | CIV | |
## Azd | CHB |
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- ยป Electron transfer pathway
- ยป Fatty acid oxidation pathway control state, F
- ยป NADH electron transfer-pathway state, N
- ยป Succinate pathway control state, S
- ยป NS-pathway control state, NS
- ยป Glycerophosphate pathway control state, Gp
- ยป Complex IV single step, CIV
- ยป Anaplerotic pathway control state
- Pathway control
- Main fuel substrates
- ยป Glutamate, G
- ยป Glycerophosphate, Gp
- ยป Malate, M
- ยป Octanoylcarnitine, Oct
- ยป Pyruvate, P
- ยป Succinate, S
- Main fuel substrates
- Glossary